Global investors have overlooked these solid stocks going for growth
Nisha Thakrar, investment specialist at Nedgroup Investments, selects three undervalued stocks with long-term growth potential
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
You are now subscribed
Your newsletter sign-up was successful
Want to add more newsletters?
Twice daily
MoneyWeek
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Four times a week
Look After My Bills
Sign up to our free money-saving newsletter, filled with the latest news and expert advice to help you find the best tips and deals for managing your bills. Start saving today!
In today’s environment of elevated uncertainty and short-term noise, the Nedgroup Investments Contrarian Value Equity Fund offers a clear alternative for long-term investors. Our philosophy is rooted in high conviction and patience. We are not chasing controversy or buying what is merely cheap. We are identifying durable businesses with the capacity to compound earnings over time. Through a rigorous bottom-up approach, we build a portfolio of between 30 and 50 companies from around the world with resilient fundamentals: defensible competitive positions, clear growth paths, trustworthy management teams and robust balance sheets.
Investment returns in excess of the benchmark index, in our view, are earned through stock selection, thoughtful position sizing and valuation discipline, both at entry and exit. We assess long-term intrinsic value across a range of outcomes, with particular emphasis on downside risk, and build positions incrementally. This long-term, unemotional approach allows us to build conviction in contrarian times when others might retreat. We look for misunderstood firms where quality is mispriced and long-term earnings power is underappreciated. Three recent additions to the portfolio reflect this mindset.
Three stocks to watch
Amrize (NYSE: AMRZ) is a building-materials company newly spun-off from Holcin, and is focused on North America, where secular tailwinds (such as investment in infrastructure, the undersupply of housing and onshoring) are underpinning long-term demand. With more than 1,000 sites and deep mineral reserves, it benefits from scale, vertical integration and proximity to key markets.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
We’ve known this management team throughout our long-term investment in Holcim, and believe that its disciplined capital allocation and operating efficiency will allow Amrize to boost earnings over the long term by expanding margins and making strategic acquisitions. As a standalone entity, Amrize remains underappreciated, creating a rerating opportunity as the market begins to recognise its true value.
Hoshizaki (Tokyo: 6465) is a global leader in commercial refrigeration and ice-making equipment, serving hotel chains, restaurants, supermarkets, and convenience stores. While it is domiciled in Japan, its reach is global. The company’s strong brand, reliable products and entrenched relationships with distributors create a durable competitive advantage in a fragmented market. Given steady demand for replacement products and long-term growth in the sector, Hoshizaki offers resilient profits. Its conservative balance sheet and engineering-led culture support margin improvement through automation and global sourcing.
Becton Dickinson (NYSE: BDX) is a “picks-and-shovels” business for healthcare: it provides essential products such as syringes, catheters, and laboratory instruments to hospitals, laboratories and research centres. These categories carry high regulatory and trust barriers, and Becton Dickinson is a global leader in many of them. Its recurring revenue base is less sensitive to economic cycles and more aligned with long-term demographic and healthcare trends. Disciplined mergers and acquisitions, a focus on patients’ safety and expansion into emerging markets support consistent earnings growth. Becton’s ability to innovate while maintaining operational discipline makes it a durable compounder in our portfolio.
This article was first published in MoneyWeek's magazine. Enjoy exclusive early access to news, opinion and analysis from our team of financial experts with a MoneyWeek subscription.
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Nisha joined Nedgroup Investments in 2023 and is the Product Specialist for the Nedgroup Investments Contrarian Value Equity fund. She has more than two decades of experience engaging with retail and institutional clients across asset classes. Nisha was previously at Capital Group where she was an investment specialist for the multi-asset solutions business, senior manager of the product development team in Europe and held various other roles.
-
Should you buy an active ETF?ETFs are often mischaracterised as passive products, but they can be a convenient way to add active management to your portfolio
-
Power up your pension before 5 April – easy ways to save before the tax year endWith the end of the tax year looming, pension savers currently have a window to review and maximise what’s going into their retirement funds – we look at how
-
Three key winners from the AI boom and beyondJames Harries of the Trojan Global Income Fund picks three promising stocks that transcend the hype of the AI boom
-
RTX Corporation is a strong player in a growth marketRTX Corporation’s order backlog means investors can look forward to years of rising profits
-
Profit from MSCI – the backbone of financeAs an index provider, MSCI is a key part of the global financial system. Its shares look cheap
-
'AI is the real deal – it will change our world in more ways than we can imagine'Interview Rob Arnott of Research Affiliates talks to Andrew Van Sickle about the AI bubble, the impact of tariffs on inflation and the outlook for gold and China
-
Should investors join the rush for venture-capital trusts?Opinion Investors hoping to buy into venture-capital trusts before the end of the tax year may need to move quickly, says David Prosser
-
Food and drinks giants seek an image makeover – here's what they're doingThe global food and drink industry is having to change pace to retain its famous appeal for defensive investors. Who will be the winners?
-
Barings Emerging Europe trust bounces back from Russia woesBarings Emerging Europe trust has added the Middle East and Africa to its mandate, delivering a strong recovery, says Max King
-
How a dovish Federal Reserve could affect youTrump’s pick for the US Federal Reserve is not so much of a yes-man as his rival, but interest rates will still come down quickly, says Cris Sholto Heaton
